The New Jersey Superior Court’s appellate division refused to reinstate a hernia mesh product liability lawsuit against Becton Dickinson's C.R. Bard because expert witnesses couldn't prove the design of the product was defective or that significant negligence occurred.
News & Features
In 2017 Netflix brought Bill Nye back to television, this time with a talk show for adults. In this guide, we highlight episodes from the first two seasons of Bill Nye Saves the World that medtech professionals should appreciate.
Endologix reported positive results from ENCORE, a pooled analysis of several prospective studies evaluating polymer endovascular aneurysm repair using the company's Ovation abdominal stent graft systems.
Colibri has treated the first two patients in a feasibility study and cites Edwards Lifesciences as its main competition in the TAVR market.
Amazon has reportedly hooked a former FDA officer for its new healthcare business, but we still don't know much about this secretive new venture.
These medical devices are on a commercialization track to heal the patient of tomorrow in a way that’s substantially better than previous offerings.
Partnership aims to connect as many devices as possible, even a bare syringe, to help improve patient adherence.
We asked readers to weigh in on Theranos founder and CEO Elizabeth Holmes's recent SEC settlement over fraud charges. Here's what survey respondents had to say about it.
Johnson & Johnson continues its exodus from the diabetes market and has received a $2.1B offer from Platinum Equity to acquire LifeScan.
A new study has confirmed the accuracy of the Xpresys Lung 2 test developed by Integrated Diagnostics.
Corindus Vascular tops revenue expectations for the fourth quarter of 2017 and gears up for tele-stenting trial with Mayo Clinic.
Texas A&M is launching a new engineering-based medical degree program in partnership with Houston Methodist Hospital that will educate a new kind of doctor with an engineering mindset.